Results 41 to 50 of about 5,155,633 (254)

Ocular Vascular Events following COVID-19 Vaccines: A Systematic Review

open access: yes, 2022
The main aim of this study is to investigate the current evidence regarding the association between COVID-19 vaccination and ocular vascular events. The protocol is registered on PROSPERO (CRD42022358133).
Irshaidat, Sara   +19 more
core   +1 more source

COVID-19 vaccine acceptance and adherence to non-pharmaceutical interventions among employees of public transportations company in Addis Ababa, Ethiopia

open access: yesHuman Vaccines & Immunotherapeutics, 2023
This study examined the acceptability of the COVID-19 vaccines and measured adherence to non-pharmaceutical interventions among employees in public transportations in Addis Ababa, Ethiopia.
Abebe Debu Liga   +2 more
doaj   +1 more source

COVID-19 vaccination coverage and its cognitive determinants among older adults in Shanghai, China, during the COVID-19 epidemic

open access: yesFrontiers in Public Health, 2023
ObjectivesThis study aimed to examine the coverage of coronavirus disease 2019 (COVID-19) vaccination and its cognitive determinants among older adults.MethodsA cross-sectional study was conducted using a questionnaire to conduct a survey among 725 ...
Lu Wei   +7 more
doaj   +1 more source

Covid- 19 Vaccines Apathy in Rural Nigerian Communities

open access: yesActa Universitatis Danubius: Administratio, 2023
The emergence of Covid -19 in Wuhan China, and its declaration as a global pandemic by the World Health Organization (WHO) raises series of concerns across different nations of the world.
Olumide Ajayi, Olabisi Ajayi-Oluajayi
doaj  

Factors associated with COVID-19 booster vaccine willingness among migrants from the Eastern Mediterranean living in Australia: a cross-sectional study

open access: yesBMC Public Health, 2022
Background Migrants have been disproportionally affected by COVID-19 in Australia. Vaccination against COVID-19 is a key pillar of Australia's public health response, but little is known about the willingness to receive booster vaccinations among ...
Keeley Allen   +3 more
doaj   +1 more source

Cognitive Factors Influencing COVID-19 Vaccination Intentions: An Application of the Protection Motivation Theory Using a Probability Community Sample

open access: yesVaccines, 2021
COVID-19 vaccines have been shown to provide protection against severe disease and death. However, substantial individual differences in vaccination intentions have hindered achieving optimal vaccination rates across the population. To look for efficient
Kwok Kit Tong   +4 more
doaj   +1 more source

Nanomedicine and the COVID-19 vaccines [PDF]

open access: yesNature Nanotechnology, 2020
Two nanoparticle-based vaccines close to obtaining approval by the US Food and Drug Administration could represent a giant step in the fight against the COVID-19 pandemic.
openaire   +2 more sources

COVID-19: State of the Vaccination [PDF]

open access: yesDrugs & Therapy Perspectives, 2021
The emergence of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the resulting coronavirus disease 2019 (COVID-19) pandemic has led to rapid vaccine development and emergency use (EU) rollout. Six vaccines, including two using novel mRNA technology, are EU-listed by the World Health Organisation, and promising published trial data ...
Fenton, Caroline, Lamb, Yvette N.
openaire   +2 more sources

Predictors of COVID-19 vaccine hesitancy among Egyptian healthcare workers: a cross-sectional study

open access: yesBMC Infectious Diseases, 2021
Background Coronavirus disease 2019 (COVID-19) vaccination has raised concerns about vaccine hesitancy in general and COVID-19 vaccine hesitancy in particular.
Rehab H. El-Sokkary   +6 more
doaj   +1 more source

Fluvoxamine for Outpatient Treatment of COVID-19: A Decentralized, Placebo-controlled, Randomized, Platform Clinical Trial

open access: yes, 2022
BACKGROUND: The effectiveness of fluvoxamine to shorten symptom duration or prevent hospitalization among outpatients in the US with mild to moderate symptomatic coronavirus disease 2019 (COVID-19) is unclear. DESIGN: ACTIV-6 is an ongoing, decentralized,
Boulware, David R.   +27 more
core   +1 more source

Home - About - Disclaimer - Privacy